| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $45.6M | -5.7% |
| Cost of Revenue | $24.2M | +17.6% |
| R&D Expense | $9.9M | +36.5% |
| SG&A Expense | $52.0M | +16.8% |
| Operating Income | -$46.1M | -91.3% |
| Interest Expense | $2.4M | -6.7% |
| Income Tax | -$282K | -261.1% |
| Net Income | -$47.4M | -76.5% |
| EPS (Basic) | -$2.77 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $62.4M | -37.3% |
| Accounts Receivable | $6.1M | -37.1% |
| Current Assets | $72.6M | -35.6% |
| Total Assets | $86.2M | -30.2% |
| Current Liabilities | $9.6M | +3.3% |
| Long-term Debt | $29.0M | +5.4% |
| Total Liabilities | $43.8M | +13.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.1M | -58.6% |
| Capital Expenditures | $4.3M | +82.2% |
| Investing Cash Flow | -$4.3M | -78.4% |
| Financing Cash Flow | -$489K | -100.8% |
| Free Cash Flow | -$36.5M | -61.1% |
| -64.9% |
| EPS (Diluted) | -$2.77 | -64.9% |
| Stockholders' Equity |
| $42.5M |
| -50.0% |